Omar (@omar__azem) 's Twitter Profile
Omar

@omar__azem

Neomed ‘21 | PGY-4 | #RadOnc @ Rush University Medical Center ☢️

ID: 1042057321118085121

calendar_today18-09-2018 14:26:40

41 Tweet

126 Takipçi

170 Takip Edilen

RUSH Radiation Oncology (@rushradonc) 's Twitter Profile Photo

Thanks to #radonc mentor extraordinaire Dr. Charles Thomas from Radiation Oncology | Dartmouth Cancer Center for spending the day with us RUSH Radiation Oncology as a visiting professor. So many words of wisdom about management of thymic malignancies, mentorship, & leadership. "Onwards!" Rush University System for Health RUSH Cancer Center

Thanks to #radonc mentor extraordinaire Dr. Charles Thomas from <a href="/DHMC_RadOnc/">Radiation Oncology | Dartmouth Cancer Center</a> for spending the day with us <a href="/RushRadOnc/">RUSH Radiation Oncology</a> as a visiting professor. So many words of wisdom about management of thymic malignancies, mentorship, &amp; leadership. "Onwards!"
<a href="/RushMedical/">Rush University System for Health</a> <a href="/RushCancer/">RUSH Cancer Center</a>
Omar (@omar__azem) 's Twitter Profile Photo

If a mucosal melanoma ever sneaks onto your patient list, we’ve got you covered🫡 Check out our review on Radiation Therapy in the Management of HNMM mdpi.com/2974640 #mdpicancers via Cancers MDPI Nikhil Joshi Michael Jelinek

RUSH Radiation Oncology (@rushradonc) 's Twitter Profile Photo

Omar, PGY4 RUSH Radiation Oncology, kicking off #ASTRO24 with a prostate quick pitch "Impact of Prior Local Therapy (LT) on Treatment Response and Survival of Men with Metastatic Castrate Resistant Prostate Cancer (mCRPC): A Pooled Analysis of COU-AA-302 and ACIS Trials"

<a href="/Omar__Azem/">Omar</a>, PGY4 <a href="/RushRadOnc/">RUSH Radiation Oncology</a>, kicking off #ASTRO24 with a prostate quick pitch "Impact of Prior Local Therapy (LT) on Treatment Response and Survival of Men with Metastatic Castrate Resistant Prostate Cancer (mCRPC): A Pooled Analysis of COU-AA-302 and ACIS Trials"
Julian Chavarriaga (@chavarriagaj) 's Twitter Profile Photo

#ASTRO24 A post-hoc unplanned pooled Analysis of COU-AA-302 and ACIS Trials exploring the impact of prior local therapy on Tx response and OS of men with mCRPC was presented by Omar The key takeaways of this presentation were: 🚩1,132 received prior LT (RP/ RT), 22% had

#ASTRO24 A post-hoc unplanned pooled Analysis of COU-AA-302 and ACIS Trials exploring the impact of prior local therapy on Tx response and OS of men with mCRPC was presented by <a href="/Omar__Azem/">Omar</a> The key takeaways of this presentation were:

🚩1,132 received prior LT (RP/ RT), 22% had
UroToday.com (@urotoday) 's Twitter Profile Photo

Impact of prior local therapy on treatment response and survival of men with #mCRPC: a pooled analysis of COU-AA-302 and #ACIS trials. Presentation by Omar RUSH Radiation Oncology. #ASTRO24 written coverage by Julian Chavarriaga University of Toronto > bit.ly/3zt1YUx ASTRO

Impact of prior local therapy on treatment response and survival of men with #mCRPC: a pooled analysis of COU-AA-302 and #ACIS trials. Presentation by <a href="/Omar__Azem/">Omar</a> <a href="/RushRadOnc/">RUSH Radiation Oncology</a>. #ASTRO24 written coverage by <a href="/chavarriagaj/">Julian Chavarriaga</a> <a href="/UofT/">University of Toronto</a> &gt; bit.ly/3zt1YUx <a href="/ASTRO_org/">ASTRO</a>
Urology Times (@urologytimes) 's Twitter Profile Photo

The survival outcomes linked to ARPIs are not significantly compromised due to prior local therapy among patients with #mCRPC, according to late-breaking data presented by Omar of RUSH Radiation Oncology today. Read more: urologytimes.com/view/prior-loc… #ASTRO24 #ASTRO #RadOnc